Markets

  1. Home
Market Nav

PIRAMAL PHARMA LTD.

  • NSE CodePPLPHARMAEQ
  • BSE Code543635
  • ISININE0DK501011
  • IndustryPharmaceuticals

Company Information

Management

Incorporation Year

04/03/2020

Registered Address

Registered Office : Ground Floor, Piramal Ananta, Agastya Corporate Park, Kamani Junction,LBS Marg, Kurla (West),
Mumbai, Maharashtra - 400070
Tel: 022-38023000, 38024000

Registrar Office

MUFG Intime India Pvt. Ltd.
C 101, 247 Park, L.B.S. Marg, Vikhroli (West)
Mumbai,400083,Maharashtra
Tel: 022-49186270
Fax: 49186060

Email

shareholders.ppl@piramal.com

Website

http://www.piramalpharma.com

Listing

BSE, BSE, BSE, NSE, NSE

Corporate News

Piramal Pharma - Announcement under Regulation 30 (LO...

22-Jul-2025|10:01AM

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure

Piramal Pharma has submitted to BSE the Shareholding ...

22-Jul-2025|7:05AM

As of June 2025, 34.85% is owned by Indian Promoters, 64.57% by Public and

Piramal Pharma - Credit Rating- Revision

21-Jul-2025|12:39PM

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclos

Piramal Pharma - Announcement under Regulation 30 (LO...

21-Jul-2025|12:33PM

Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclos

More

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug67.10190.26
Aarti Drug536.754,898.92
Aarti Pharma934.608,470.71
Abbott India34,130.0072,523.87
Accent Micro277.95666.77
More

MF Holding

Scheme NameValue
(₹ Cr)		Holding (%)
HDFC Fl..1784.422.24
HDFC Fo..508.452.44
Canara ..136.521.04
Bandhan..107.070.82
Canara ..64.060.57
More

Board Meetings

DatePurpose
28/07/2025Quarterly Results
14/05/2025Audited Results & F..
28/01/2025Quarterly Results
23/10/2024Quarterly Results
26/07/2024Quarterly Results
More